Mechanisms of Oral Tolerance

Pediatric Clinics of North America

Volumn 62, Issue 6, 2015, Pages 1523-1529

  Commins, Scott P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Food allergy; Mucosal; Oral antigen; Tolerance

Indexed keywords

CD3 ANTIBODY; IMMUNOGLOBULIN E;

CLONAL ANERGY; FOOD ALLERGY; GUT IMMUNE SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; MOLECULAR RECOGNITION; NONHUMAN; ORAL IMMUNOTHERAPY; REGULATORY T LYMPHOCYTE; REVIEW; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CHILD; GASTROINTESTINAL TRACT; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; T LYMPHOCYTE SUBPOPULATION;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CHILD; FOOD HYPERSENSITIVITY; GASTROINTESTINAL TRACT; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN E; MICROBIOTA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84943585889     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2015.07.013     Document Type: Review

References (51)

1. Moog F. The lining of the small intestine. Sci Am 1981, 245(5):154-158. 160, 162 et passiom.
2. Brandtzaeg P. Development and basic mechanisms of human gut immunity. Nutr Rev 1998, 56(1 Pt 2):S5-S18.
3. Macfarlane G.T., Macfarlane S. Human colonic microbiota: ecology, physiology and metabolic potential of intestinal bacteria. Scand J Gastroenterol Suppl 1997, 222:3-9.
4. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003, 3(4):331-341.
5. Mowat A.M., Donachie A.M., Parker L.A., et al. The role of dendritic cells in regulating mucosal immunity and tolerance. Novartis Found Symp 2003, 252:291-302. [discussion: 302-5].
6. Rescigno M. Functional specialization of antigen presenting cells in the gastrointestinal tract. Curr Opin Immunol 2010, 22(1):131-136.
7. Sheridan B.S., Lefrançois L. Intraepithelial lymphocytes: to serve and protect. Curr Gastroenterol Rep 2010, 12(6):513-521.
8. Ke Y., Pearce K., Lake J.P., et al. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997, 158(8):3610-3618.
9. Strober W. The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity 2009, 31(3):377-388.
10. Izcue A., Coombes J.L., Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006, 212:256-271.
11. Li M.O., Flavell R.A. TGF-beta: a master of all T cell trades. Cell 2008, 134(3):392-404.
12. Mowat A.M. Basic mechanisms and clinical implications of oral tolerance. Curr Opin Gastroenterol 1999, 15(6):546-556.
13. Vickery B.P., Burks A.W. Immunotherapy in the treatment of food allergy: focus on oral tolerance. Curr Opin Allergy Clin Immunol 2009, 9(4):364-370.
14. Peron J.P., de Oliveira A.P., Rizzo L.V. It takes guts for tolerance: the phenomenon of oral tolerance and the regulation of autoimmune response. Autoimmun Rev 2009, 9(1):1-4.
15. Wang J., Toes R.E. Mechanisms of oral tolerance revisited. Arthritis Res Ther 2008, 10(2):108.
16. Pabst O., Mowat A.M. Oral tolerance to food protein. Mucosal Immunol 2012, 5(3):232-239.
17. Weiner H.L., da Cunha A.P., Quintana F., et al. Oral tolerance. Immunol Rev 2011, 241(1):241-259.
18. Burks A.W., Laubach S., Jones S.M. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008, 121(6):1344-1350.
19. Chen Y.H., Weiner H.L. Dose-dependent activation and deletion of antigen-specific T cells following oral tolerance. Ann N Y Acad Sci 1996, 778:111-121.
20. Friedman A., Weiner H.L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A 1994, 91(14):6688-6692.
21. Dubois B., Joubert G., Gomez de Agüero M., et al. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 2009, 137(3):1019-1028.
22. Mucida D., Park Y., Kim G., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317(5835):256-260.
23. Chen Y., Kuchroo V.K., Inobe J., et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265(5176):1237-1240.
24. Zhang Z.J., Davidson L., Eisenbarth G., et al. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci U S A 1991, 88(22):10252-10256.
25. Miller A., Lider O., Roberts A.B., et al. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 1992, 89(1):421-425.
26. Thorstenson K.M., Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001, 167(1):188-195.
27. Tsuji N.M., Mizumachi K., Kurisaki J. Interleukin-10-secreting Peyer's patch cells are responsible for active suppression in low-dose oral tolerance. Immunology 2001, 103(4):458-464.
28. Chen Y., Inobe J., Weiner H.L. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J Immunol 1995, 155(2):910-916.
29. Lider O., Santos L.M., Lee C.S., et al. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 1989, 142(3):748-752.
30. Schietinger A., Delrow J.J., Basom R.S., et al. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science 2012, 335(6069):723-727.
31. Macián F., García-Cózar F., Im S.H., et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002, 109(6):719-731.
32. Ise W., Nakamura K., Shimizu N., et al. Orally tolerized T cells can form conjugates with APCs but are defective in immunological synapse formation. J Immunol 2005, 175(2):829-838.
33. Mirenda V., Millington O., Lechler R.I., et al. Tolerant T cells display impaired trafficking ability. Eur J Immunol 2005, 35(7):2146-2156.
34. Song F., Guan Z., Gienapp I.E., et al. The thymus plays a role in oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 2006, 177(3):1500-1509.
35. Vickery B.P., Scurlock A.M., Kulis M., et al. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014, 133(2):468-475.
36. Chen Y., Inobe J., Kuchroo V.K., et al. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A 1996, 93(1):388-391.
37. Chen Y., Inobe J., Marks R., et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995, 376(6536):177-180.
38. Chatenoud L., Bluestone J.A. CD3-specific antibodies: a portal to the treatment of autoimmunity. Nat Rev Immunol 2007, 7(8):622-632.
39. Ochi H., Abraham M., Ishikawa H., et al. Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells. Nat Med 2006, 12(6):627-635.
40. Husby S., Jensenius J.C., Svehag S.E. Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol 1985, 22(1):83-92.
41. Commins S.P., James H.R., Stevens W., et al. Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2014, 134(1):108-115.
42. Warshaw A.L., Walker W.A. Intestinal absorption of intake antigenic protein. Surgery 1974, 76(3):495-499.
43. Walker W.A., Isselbacher K.J. Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology 1974, 67(3):531-550.
44. Peng H.J., Turner M.W., Strobel S. The generation of a 'tolerogen' after the ingestion of ovalbumin is time-dependent and unrelated to serum levels of immunoreactive antigen. Clin Exp Immunol 1990, 81(3):510-515.
45. Thomson A.W., Knolle P.A. Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010, 10(11):753-766.
46. Callery M.P., Kamei T., Flye M.W. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J Surg Res 1989, 46(4):391-394.
47. Yang R., Liu Q., Grosfeld J.L., et al. Intestinal venous drainage through the liver is a prerequisite for oral tolerance induction. J Pediatr Surg 1994, 29(8):1145-1148.
48. Pabst O., Bernhardt G., Förster R. The impact of cell-bound antigen transport on mucosal tolerance induction. J Leukoc Biol 2007, 82(4):795-800.
49. Förster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8(5):362-371.
50. Worbs T., Bode U., Yan S., et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006, 203(3):519-527.
51. Spahn T.W., Weiner H.L., Rennert P.D., et al. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002, 32(4):1109-1113.